PROSPERA™ SPINAL CORD STIMULATOR WITH EMBRACE ONE™
See why the Prospera SCS System is uniquely designed to relieve your chronic pain—and support you in embracing life again.
THE PAINFUL TRUTH ABOUT CHRONIC PAIN
If you are living with chronic pain, you feel the impact it has on your everyday life. It affects you not just physically, but mentally and emotionally as well. For many, this can mean:
It can often feel like you are alone in your struggles, but you aren’t.
An estimated 100 million adults in the US suffer from chronic pain.1
The path to relief can be challenging. If you’ve tried medications or other pain management therapy without success, don’t give up hope. Spinal cord stimulation (SCS) therapy could provide the relief you’ve been searching for. While SCS isn't a cure for the cause of your pain, millions of people over the past 50+ years have used SCS.2 Many have found it to be a safe and successful therapy to help get their lives back.3
UNDERSTANDING SPINAL CORD STIMULATION
As you know, there are many treatment options for chronic pain. One you may be less familiar with is spinal cord stimulation, or SCS. SCS works by using small electrical impulses to interrupt pain signals before they reach the brain.
SCS CAN PROVIDE3-5:
- EFFECTIVE PAIN RELIEF
- IMPROVED QUALITY OF LIFE
- IMPROVED OVERALL MOVEMENT
- IMPROVED SLEEP
- REDUCED DEPENDENCE ON MEDICATION
HOW SCS THERAPY WORKS:
Thin leads are placed near specific nerves in your back and attached to a small implanted stimulator.
SCS therapy travels from the stimulator through the leads to communicate with your nerves.
The stimulation is designed to interrupt and mask the pain signals as they travel to the brain.
You are given a programmer, which is a phone-like device that allows you to control your therapy.
THE UNIQUE BIOTRONIK NEURO ADVANTAGE
The Prospera™ SCS System
MRI for Real Life
Proactive Care** with Embrace One™
The Embrace One™ App
Get reliable relief from your chronic pain. Only the Prospera SCS System has RESONANCE™, a proprietary therapy that leverages how the body processes pain. It was designed to stimulate a broader area of your nerves.6
With RESONANCE therapy, patients experienced7:
- Significant reduction in pain
- Overall improvements in quality of life, including sleep
TRY THE PROSPERA SCS SYSTEM TO SEE IF IT’S RIGHT FOR YOU
Unlike other treatment options, you can test SCS therapy during a trial period to see how it works for you before committing long term.
HERE’S HOW THE PROSPERA SCS SYSTEM TRIAL PERIOD WORKS
1. Temporary leads are placed near specific nerves in your back during a simple in-office procedure.
2. The leads are connected to a small, discreet external stimulator you wear under your clothes.
3. You go about your daily activities, which gives you a chance to see how Prospera SCS can easily fit into your life and provide relief.
4. You, your doctor, and your Embrace One Care Team will monitor any pain relief, improvements in function, and other benefits you may experience.
5. If you and your doctor decide Prospera SCS is the right long-term therapy for you, you can rest assured that your dedicated Embrace One Care Team will be with you every step of the way.
Get the MRI you may need8:
- The only SCS system that allows you to get full-body 1.5T and 3T scans
- Peace of mind that you have access to the most advanced scans
Embrace One* is unique: it is the only patient support system that allows for automatic, daily, remote monitoring of your therapy. Your Embrace One Care Team is made up of trained, dedicated specialists who monitor your therapy 7 days a week to ensure that it is working the best for you.**
The Embrace One Care Team consists of trained, dedicated specialists who monitor your therapy 7 days a week.
If they detect that any adjustments may be needed, the team will proactively reach out to you.
Your therapy can be fine-tuned for the best possible relief through a remote programming session, anytime and anywhere.
Your doctor and Embrace One Care Team work together to monitor your therapy, ensuring it is working the best for you.**
All data is transmitted using state-of-the-art security and protection.
You are supported by the Embrace One Care Team for the lifetime of your therapy.
The Embrace One app, an optional resource, can help you in your journey with the Prospera SCS System.
Key features of the Embrace One App
- Create your own goals
- Log your pain, mood, sleep, function, and activity
- Track your journey and see next steps
- Stay informed through educational content, including documents and videos
- Access FAQs
NOTIFICATIONS (coming soon)
- Appointment notifications
MEET YOUR TEAM
- Meet your dedicated BIOTRONIK Neuro team members who are here to support you
KEEP TRACK OF QUESTIONS
- Remember what to ask your Embrace One Care Team with a questions list
Schedule an appointment with your doctor to discuss Prospera SCS
*Embrace One is a support platform intended to help manage a patient's experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.
**Proactive Care: BIOTRONIK Neuro's remote support team may reach out to patients to ensure proper usage of the spinal cord stimulator based on remotely monitored data. BIOTRONIK Neuro does not provide health advice or clinical actions outside the scope of spinal cord stimulator proper usage. This product support is not a replacement for the patient's responsibility to communicate any medical questions or concerns with the physician's office.
REFERENCES:1. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011. 2. International Neuromodulation Society. Accessed March 16, 2023.
https://www.neuromodulation.com/spinal-cord-stimulation 3. Grider JS, Manchikanti L, Carayannopoulos A, et al. Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Physician. 2016;19(1):E33-E54. 4. Pollard EM, Lamer TJ, Moeschler SM, et al. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. J Pain Res. 2019;12:1311-1324. 5. Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain. 2008;12(8):1047-1058. 6. Slee SJ, Lim K, Riahi PSV, et al. Functional ultrasound reveals activation properties of clinical spinal cord stimulation therapy. Poster presented at: The International Neuropsychological Society Annual Meeting; July 6, 2022; Barcelona, Spain. 7. Russo M, Yu J, Mohabbati V, Amirdelfan K, Kapural L, Verrills P. 3-month study results for an implantable SCS system with multiphase stimulation and remote device management. Poster presented at: 26th Annual North American Neuromodulation Society Meeting; January 12-15, 2023; Las Vegas, NV. 8. Prospera Spinal Cord Stimulation System, MRI Guidelines Technical Manual. Document 461825, Revision C. Biotronik Neuro. Lake Oswego, OR; July 2022.
Brief Summary: Please reference the appropriate product Instructions for Use (IFU) for more information regarding indications, contraindications, warnings, precautions, and potential adverse events. Indications for Use: The Prospera™ Spinal Cord Stimulation (SCS) System is indicated as an aid in the management of chronic, intractable pain in the trunk and/or limbs, which may include unilateral or bilateral pain. Contraindications: Implantation of a spinal cord stimulator may be contraindicated in patients who are unable to operate the SCS system, or who have failed to receive effective pain relief during SCS trial stimulation, or who are poor candidates for surgery. Note that the safety and effectiveness of Prospera SCS system has not been established in pediatric patients or pregnant or nursing patients. Warnings: The following may cause electromagnetic interference, adverse interactions, insufficient or excessive stimulation, damage and function loss of the system, and/or therapy failure: external defibrillation, transcutaneous electrical nerve stimulation (TENs), lithotripsy, RF ablation, hyperbaric oxygen therapy, electrocautery, diathermy therapy (including shortwave, microwave, and therapeutic ultrasound therapies), high-power ultrasound, radiation therapy, Magnetic Resonance Imaging (MRI) scan (refer to Prospera SCS System MRI Guidelines for the system’s MR conditional information), use of portable RF communication equipment near the SCS system, use of a non-BIOTRONIK-provided charger. The Prospera SCS System may interfere with the operation of implanted pacemakers or ICDs. The effects of an implanted Prospera SCS System on other neurostimulators are unknown. Precautions: Device malfunction, loss of therapy, and other adverse events including patient injury may occur if the device is not handled or operated properly as described in the IFU. Refer to the product IFU for comprehensive safety messages when handling the device. Potential Adverse Events: Risks associated with SCS system placement: pain at the implant site, infection, cerebrospinal fluid (CSF) leakage, CSF fistula, epidural hemorrhage, bacterial meningitis, seroma, hematoma, paralysis. Additional risks associated with SCS system use: lead migration; stimulator migration; allergic response or tissue reaction to the implanted system material; skin erosion; radicular chest wall stimulation; disturbed urination; dysesthesia; decubitus; premature battery depletion; and uncomfortable stimulation or ineffective pain management. Furthermore, there is the risk that the SCS therapy may not be effective in relieving symptoms or may cause worsening of symptoms. Refer to the product IFU for a comprehensive list of potential adverse events.